Biological Monitoring by a Nurse for Heart Failure Patients. (IC-SPEC)

Hôpital NOVO

Status: Active, not recruiting

Conditions: Heart Failure

Treatments: Other: Remote biological monitoring by a heart failure nurse

Study type: Observational

Funder types: Other

Identifiers

NCT05782075

CHRD0323

Details and patient eligibility

About

The aim of this study is to evaluate the feasibility and safety of delegating remote biological monitoring in post-hospitalization for cardiac decompensation by a heart failure nurse.

Full description

Chronic heart failure is a major public health issue in France. It is the leading cause of hospitalisation in people over 65 years of age and results in many costly and potentially avoidable hospital stays. One third of patients are readmitted to hospital within 3 months of discharge.

A remote monitoring programme and natriuretic peptide monitoring during this vulnerable period can help improve patient management, reducing rehospitalisation rates, emergency room visits and mortality.

Given the increasing pressure on already limited healthcare resources, it is important to examine the delegation of care to specialist nurses, as well as their safety.

This study aims to evaluate the feasibility and safety of delegating remote biological monitoring in post-hospitalization for cardiac decompensation by a heart failure nurse.

Enrollment: 100 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient ≥18 years old,
• Patient hospitalised for heart failure and discharged,
• Glomerular filtration rate at discharge > 20ml/min/1.73m²,
• Patient informed and agree to participate,
• Patient able to carry out the follow-up proposed by the cardiology department.

Exclusion criteria

• Cognitive disorders with Codex test category C and D,
• Barrier of the language,
• Psychiatric disorder that may interfere with treatment,
• Major surgery scheduled within 3 months,
• Excessive alcohol or drug use with no desire to withdraw
• Cardiac amyloidosis,
• Terminal heart failure,
• Patient discharged to specialised Care and Rehabilitation department,
• Any disease other than cardiac with a life expectancy of less than 1 year according to the investigator,
• Patient under guardianship,